Industry Research Reports
Home > Reports > Chemical & Material > Global Poly(L-lactide-co-caprolactone) Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Poly(L-lactide-co-caprolactone) Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-11-08
Pages: 111 Pages
Report ld: 5384220
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Poly(L-lactide-co-caprolactone) Market Size(US$)
CAGR 2025-2031
7.2%
Market Size,2031
USD 27.5
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 18.1 million
Market Forecast in 2031(Value)
US$ 27.5 million
CAGR
7.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Poly(L-lactide-co-caprolactone) market is projected to grow from US$ 17 million in 2024 to US$ 27.5 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
From a downstream perspective, Absorbable Suture accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Poly(L-lactide-co-caprolactone) leading manufacturers including Evonik, BMG, KD Finechem, Nomisma Healthcare, etc., dominate supply; the top five capture approximately % of global revenue, with Evonik leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Poly(L-lactide-co-caprolactone) market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Evonik
- BMG
- KD Finechem
- Nomisma Healthcare
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- LCL(75:25)
- LCL(70:30)
- LCL(50:50)
- Others
Segment by Application
- Absorbable Suture
- Drug Delivery
- Tissue Engineering
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Poly(L-lactide-co-caprolactone) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Poly(L-lactide-co-caprolactone): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Poly(L-lactide-co-caprolactone) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 LCL(75:25)
1.2.3 LCL(70:30)
1.2.4 LCL(50:50)
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Poly(L-lactide-co-caprolactone) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Absorbable Suture
1.3.3 Drug Delivery
1.3.4 Tissue Engineering
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Poly(L-lactide-co-caprolactone) Revenue Estimates and Forecasts 2020-2031
2.2 Global Poly(L-lactide-co-caprolactone) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Poly(L-lactide-co-caprolactone) Sales Estimates and Forecasts 2020-2031
2.4 Global Poly(L-lactide-co-caprolactone) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Poly(L-lactide-co-caprolactone) Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Poly(L-lactide-co-caprolactone) Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Poly(L-lactide-co-caprolactone) Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 LCL(75:25) Market Size by Manufacturers
4.5.2 LCL(70:30) Market Size by Manufacturers
4.5.3 LCL(50:50) Market Size by Manufacturers
4.5.4 Others Market Size by Manufacturers
4.6 Global Poly(L-lactide-co-caprolactone) Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Poly(L-lactide-co-caprolactone) Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Poly(L-lactide-co-caprolactone) Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Poly(L-lactide-co-caprolactone) Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Poly(L-lactide-co-caprolactone) Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Poly(L-lactide-co-caprolactone) Sales and Revenue by Type (2020-2031)
7.4 North America Poly(L-lactide-co-caprolactone) Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Poly(L-lactide-co-caprolactone) Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Poly(L-lactide-co-caprolactone) Sales and Revenue by Type (2020-2031)
8.4 Europe Poly(L-lactide-co-caprolactone) Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Poly(L-lactide-co-caprolactone) Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Poly(L-lactide-co-caprolactone) Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Poly(L-lactide-co-caprolactone) Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Poly(L-lactide-co-caprolactone) Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Poly(L-lactide-co-caprolactone) Sales and Revenue by Type (2020-2031)
10.4 Central and South America Poly(L-lactide-co-caprolactone) Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Poly(L-lactide-co-caprolactone) Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Poly(L-lactide-co-caprolactone) Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Poly(L-lactide-co-caprolactone) Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Poly(L-lactide-co-caprolactone) Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Evonik
12.1.1 Evonik Corporation Information
12.1.2 Evonik Business Overview
12.1.3 Evonik Poly(L-lactide-co-caprolactone) Product Models, Descriptions and Specifications
12.1.4 Evonik Poly(L-lactide-co-caprolactone) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Evonik Poly(L-lactide-co-caprolactone) Sales by Product in 2024
12.1.6 Evonik Poly(L-lactide-co-caprolactone) Sales by Application in 2024
12.1.7 Evonik Poly(L-lactide-co-caprolactone) Sales by Geographic Area in 2024
12.1.8 Evonik Poly(L-lactide-co-caprolactone) SWOT Analysis
12.1.9 Evonik Recent Developments
12.2 BMG
12.2.1 BMG Corporation Information
12.2.2 BMG Business Overview
12.2.3 BMG Poly(L-lactide-co-caprolactone) Product Models, Descriptions and Specifications
12.2.4 BMG Poly(L-lactide-co-caprolactone) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 BMG Poly(L-lactide-co-caprolactone) Sales by Product in 2024
12.2.6 BMG Poly(L-lactide-co-caprolactone) Sales by Application in 2024
12.2.7 BMG Poly(L-lactide-co-caprolactone) Sales by Geographic Area in 2024
12.2.8 BMG Poly(L-lactide-co-caprolactone) SWOT Analysis
12.2.9 BMG Recent Developments
12.3 KD Finechem
12.3.1 KD Finechem Corporation Information
12.3.2 KD Finechem Business Overview
12.3.3 KD Finechem Poly(L-lactide-co-caprolactone) Product Models, Descriptions and Specifications
12.3.4 KD Finechem Poly(L-lactide-co-caprolactone) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 KD Finechem Poly(L-lactide-co-caprolactone) Sales by Product in 2024
12.3.6 KD Finechem Poly(L-lactide-co-caprolactone) Sales by Application in 2024
12.3.7 KD Finechem Poly(L-lactide-co-caprolactone) Sales by Geographic Area in 2024
12.3.8 KD Finechem Poly(L-lactide-co-caprolactone) SWOT Analysis
12.3.9 KD Finechem Recent Developments
12.4 Nomisma Healthcare
12.4.1 Nomisma Healthcare Corporation Information
12.4.2 Nomisma Healthcare Business Overview
12.4.3 Nomisma Healthcare Poly(L-lactide-co-caprolactone) Product Models, Descriptions and Specifications
12.4.4 Nomisma Healthcare Poly(L-lactide-co-caprolactone) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Nomisma Healthcare Poly(L-lactide-co-caprolactone) Sales by Product in 2024
12.4.6 Nomisma Healthcare Poly(L-lactide-co-caprolactone) Sales by Application in 2024
12.4.7 Nomisma Healthcare Poly(L-lactide-co-caprolactone) Sales by Geographic Area in 2024
12.4.8 Nomisma Healthcare Poly(L-lactide-co-caprolactone) SWOT Analysis
12.4.9 Nomisma Healthcare Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Poly(L-lactide-co-caprolactone) Industry Chain
13.2 Poly(L-lactide-co-caprolactone) Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Poly(L-lactide-co-caprolactone) Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Poly(L-lactide-co-caprolactone) Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Poly(L-lactide-co-caprolactone) Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Poly(L-lactide-co-caprolactone) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Poly(L-lactide-co-caprolactone) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Poly(L-lactide-co-caprolactone) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Poly(L-lactide-co-caprolactone) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Poly(L-lactide-co-caprolactone) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Poly(L-lactide-co-caprolactone) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Poly(L-lactide-co-caprolactone) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 7. Global Poly(L-lactide-co-caprolactone) Sales by Region (2020-2025) & (Kg)
Table 8. Global Poly(L-lactide-co-caprolactone) Sales by Region (2026-2031) & (Kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Poly(L-lactide-co-caprolactone) Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 11. Global Poly(L-lactide-co-caprolactone) Production by Region (2020-2025) & (Kg)
Table 12. Global Poly(L-lactide-co-caprolactone) Production by Region (2026-2031) & (Kg)
Table 13. Global Poly(L-lactide-co-caprolactone) Sales by Manufacturers (2020-2025) & (Kg)
Table 14. Global Poly(L-lactide-co-caprolactone) Sales Share by Manufacturers (2020-2025)
Table 15. Global Poly(L-lactide-co-caprolactone) Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Poly(L-lactide-co-caprolactone) Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Poly(L-lactide-co-caprolactone) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poly(L-lactide-co-caprolactone) as of 2024)
Table 19. Global Poly(L-lactide-co-caprolactone) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Poly(L-lactide-co-caprolactone) Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/g)
Table 21. Key Manufacturers Poly(L-lactide-co-caprolactone) Manufacturing Base and Headquarters
Table 22. Global Poly(L-lactide-co-caprolactone) Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Poly(L-lactide-co-caprolactone) Sales by Type (2020-2025) & (Kg)
Table 26. Global Poly(L-lactide-co-caprolactone) Sales by Type (2026-2031) & (Kg)
Table 27. Global Poly(L-lactide-co-caprolactone) Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Poly(L-lactide-co-caprolactone) Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Poly(L-lactide-co-caprolactone) ASP by Type (2020-2031) & (USD/g)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Poly(L-lactide-co-caprolactone) Sales by Application (2020-2025) & (Kg)
Table 32. Global Poly(L-lactide-co-caprolactone) Sales by Application (2026-2031) & (Kg)
Table 33. Poly(L-lactide-co-caprolactone) High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Poly(L-lactide-co-caprolactone) Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Poly(L-lactide-co-caprolactone) Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Poly(L-lactide-co-caprolactone) ASP by Application (2020-2031) & (USD/g)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Poly(L-lactide-co-caprolactone) Growth Accelerators and Market Barriers
Table 40. North America Poly(L-lactide-co-caprolactone) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Poly(L-lactide-co-caprolactone) Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Poly(L-lactide-co-caprolactone) Growth Accelerators and Market Barriers
Table 43. Europe Poly(L-lactide-co-caprolactone) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Poly(L-lactide-co-caprolactone) Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Poly(L-lactide-co-caprolactone) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Poly(L-lactide-co-caprolactone) Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Poly(L-lactide-co-caprolactone) Growth Accelerators and Market Barriers
Table 48. Southeast Asia Poly(L-lactide-co-caprolactone) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Poly(L-lactide-co-caprolactone) Investment Opportunities and Key Challenges
Table 50. Central and South America Poly(L-lactide-co-caprolactone) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Poly(L-lactide-co-caprolactone) Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Poly(L-lactide-co-caprolactone) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Evonik Corporation Information
Table 54. Evonik Description and Major Businesses
Table 55. Evonik Product Models, Descriptions and Specifications
Table 56. Evonik Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 57. Evonik Sales Value Proportion by Product in 2024
Table 58. Evonik Sales Value Proportion by Application in 2024
Table 59. Evonik Sales Value Proportion by Geographic Area in 2024
Table 60. Evonik Poly(L-lactide-co-caprolactone) SWOT Analysis
Table 61. Evonik Recent Developments
Table 62. BMG Corporation Information
Table 63. BMG Description and Major Businesses
Table 64. BMG Product Models, Descriptions and Specifications
Table 65. BMG Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 66. BMG Sales Value Proportion by Product in 2024
Table 67. BMG Sales Value Proportion by Application in 2024
Table 68. BMG Sales Value Proportion by Geographic Area in 2024
Table 69. BMG Poly(L-lactide-co-caprolactone) SWOT Analysis
Table 70. BMG Recent Developments
Table 71. KD Finechem Corporation Information
Table 72. KD Finechem Description and Major Businesses
Table 73. KD Finechem Product Models, Descriptions and Specifications
Table 74. KD Finechem Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 75. KD Finechem Sales Value Proportion by Product in 2024
Table 76. KD Finechem Sales Value Proportion by Application in 2024
Table 77. KD Finechem Sales Value Proportion by Geographic Area in 2024
Table 78. KD Finechem Poly(L-lactide-co-caprolactone) SWOT Analysis
Table 79. KD Finechem Recent Developments
Table 80. Nomisma Healthcare Corporation Information
Table 81. Nomisma Healthcare Description and Major Businesses
Table 82. Nomisma Healthcare Product Models, Descriptions and Specifications
Table 83. Nomisma Healthcare Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 84. Nomisma Healthcare Sales Value Proportion by Product in 2024
Table 85. Nomisma Healthcare Sales Value Proportion by Application in 2024
Table 86. Nomisma Healthcare Sales Value Proportion by Geographic Area in 2024
Table 87. Nomisma Healthcare Poly(L-lactide-co-caprolactone) SWOT Analysis
Table 88. Nomisma Healthcare Recent Developments
Table 89. Key Raw Materials Distribution
Table 90. Raw Materials Key Suppliers
Table 91. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 92. Milestones in Production Technology Evolution
Table 93. Distributors List
Table 94. Market Trends and Market Evolution
Table 95. Market Drivers and Opportunities
Table 96. Market Challenges, Risks, and Restraints
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Poly(L-lactide-co-caprolactone) Product Picture
Figure 2. Global Poly(L-lactide-co-caprolactone) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. LCL(75:25) Product Picture
Figure 4. LCL(70:30) Product Picture
Figure 5. LCL(50:50) Product Picture
Figure 6. Others Product Picture
Figure 7. Global Poly(L-lactide-co-caprolactone) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Absorbable Suture
Figure 9. Drug Delivery
Figure 10. Tissue Engineering
Figure 11. Others
Figure 12. Poly(L-lactide-co-caprolactone) Report Years Considered
Figure 13. Global Poly(L-lactide-co-caprolactone) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 15. Global Poly(L-lactide-co-caprolactone) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Poly(L-lactide-co-caprolactone) Revenue Market Share by Region (2020-2031)
Figure 17. Global Poly(L-lactide-co-caprolactone) Sales (2020-2031) & (Kg)
Figure 18. Global Poly(L-lactide-co-caprolactone) Sales (CAGR) by Region (2020-2031) (Kg)
Figure 19. Global Poly(L-lactide-co-caprolactone) Sales Market Share by Region (2020-2031)
Figure 20. Global Poly(L-lactide-co-caprolactone) Capacity, Production and Utilization (2020-2031) & (Kg)
Figure 21. Global Poly(L-lactide-co-caprolactone) Production Trend by Region (2020-2031) (Kg)
Figure 22. Global Poly(L-lactide-co-caprolactone) Production Market Share by Region (2020-2031)
Figure 23. Production Capacity Enablers & Constraints
Figure 24. Poly(L-lactide-co-caprolactone) Production Growth Rate in North America (2020-2031) & (Kg)
Figure 25. Poly(L-lactide-co-caprolactone) Production Growth Rate in Europe (2020-2031) & (Kg)
Figure 26. Poly(L-lactide-co-caprolactone) Production Growth Rate in China (2020-2031) & (Kg)
Figure 27. Poly(L-lactide-co-caprolactone) Production Growth Rate in Japan (2020-2031) & (Kg)
Figure 28. Top 5 and Top 10 Manufacturers Poly(L-lactide-co-caprolactone) Sales Volume Market Share in 2024
Figure 29. Global Poly(L-lactide-co-caprolactone) Revenue Market Share Ranking (2024)
Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 31. LCL(75:25) Revenue Market Share by Manufacturer in 2024
Figure 32. LCL(70:30) Revenue Market Share by Manufacturer in 2024
Figure 33. LCL(50:50) Revenue Market Share by Manufacturer in 2024
Figure 34. Others Revenue Market Share by Manufacturer in 2024
Figure 35. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 36. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 37. Global Poly(L-lactide-co-caprolactone) Sales Market Share by Type (2020-2031)
Figure 38. Global Poly(L-lactide-co-caprolactone) Revenue Market Share by Type (2020-2031)
Figure 39. Global Poly(L-lactide-co-caprolactone) Sales Market Share by Application (2020-2031)
Figure 40. Global Poly(L-lactide-co-caprolactone) Revenue Market Share by Application (2020-2031)
Figure 41. North America Poly(L-lactide-co-caprolactone) Sales YoY (2020-2031) & (Kg)
Figure 42. North America Poly(L-lactide-co-caprolactone) Revenue YoY (2020-2031) & (US$ Million)
Figure 43. North America Top 5 Manufacturers Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) in 2024
Figure 44. North America Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Type (2020- 2031)
Figure 45. North America Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 46. North America Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Application (2020-2031)
Figure 47. North America Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. US Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 49. Canada Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 50. Mexico Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 51. Europe Poly(L-lactide-co-caprolactone) Sales YoY (2020-2031) & (Kg)
Figure 52. Europe Poly(L-lactide-co-caprolactone) Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Europe Top 5 Manufacturers Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) in 2024
Figure 54. Europe Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Type (2020-2031)
Figure 55. Europe Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 56. Europe Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Application (2020-2031)
Figure 57. Europe Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Germany Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 59. France Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 60. U.K. Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 61. Italy Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 62. Russia Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific Poly(L-lactide-co-caprolactone) Sales YoY (2020-2031) & (Kg)
Figure 64. Asia-Pacific Poly(L-lactide-co-caprolactone) Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Asia-Pacific Top 8 Manufacturers Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) in 2024
Figure 66. Asia-Pacific Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Type (2020- 2031)
Figure 67. Asia-Pacific Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 68. Asia-Pacific Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Application (2020-2031)
Figure 69. Asia-Pacific Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Indonesia Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 71. Japan Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 72. South Korea Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 73. China Taiwan Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 74. India Poly(L-lactide-co-caprolactone) Revenue (2020-2031) & (US$ Million)
Figure 75. Central and South America Poly(L-lactide-co-caprolactone) Sales YoY (2020-2031) & (Kg)
Figure 76. Central and South America Poly(L-lactide-co-caprolactone) Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Central and South America Top 5 Manufacturers Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) in 2024
Figure 78. Central and South America Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Type (2021-2031)
Figure 79. Central and South America Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Central and South America Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Application (2020-2031)
Figure 81. Central and South America Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. Brazil Poly(L-lactide-co-caprolactone) Revenue (2020-2025) & (US$ Million)
Figure 83. Argentina Poly(L-lactide-co-caprolactone) Revenue (2020-2025) & (US$ Million)
Figure 84. Middle East, and Africa Poly(L-lactide-co-caprolactone) Sales YoY (2020-2031) & (Kg)
Figure 85. Middle East and Africa Poly(L-lactide-co-caprolactone) Revenue YoY (2020-2031) & (US$ Million)
Figure 86. Middle East and Africa Top 5 Manufacturers Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) in 2024
Figure 87. Middle East and Africa Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Type (2021-2031)
Figure 88. South America Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 89. Middle East and Africa Poly(L-lactide-co-caprolactone) Sales Volume (Kg) by Application (2020-2031)
Figure 90. Middle East and Africa Poly(L-lactide-co-caprolactone) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 91. GCC Countries Poly(L-lactide-co-caprolactone) Revenue (2020-2025) & (US$ Million)
Figure 92. Turkey Poly(L-lactide-co-caprolactone) Revenue (2020-2025) & (US$ Million)
Figure 93. Egypt Poly(L-lactide-co-caprolactone) Revenue (2020-2025) & (US$ Million)
Figure 94. South Africa Poly(L-lactide-co-caprolactone) Revenue (2020-2025) & (US$ Million)
Figure 95. Poly(L-lactide-co-caprolactone) Industry Chain Mapping
Figure 96. Regional Poly(L-lactide-co-caprolactone) Manufacturing Base Distribution (%)
Figure 97. Poly(L-lactide-co-caprolactone) Production Process
Figure 98. Regional Poly(L-lactide-co-caprolactone) Production Cost Structure
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Poly(L-lactide-co-caprolactone) market size from 2025 to 2031?
The annual compound growth rate of the global Poly(L-lactide-co-caprolactone) market is 7.2% 2025 to 2031.
Which region is expected to have the highest market share?
What was the global market size of Poly(L-lactide-co-caprolactone) in 2031?
Which companies rank high in the global Poly(L-lactide-co-caprolactone) market?
What was the global market size of Poly(L-lactide-co-caprolactone) in 2025?
Related Reports
Poly(L-lactide-co-caprolactone)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Poly(L-lactide-co-caprolactone) was estimated to be worth US$ 18.14 million in 2025 and is projected to reach US$ 29.32 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 119
USD 3950.00
(Single User License)
Global Poly(L-lactide-co-caprolactone) Market Research Report 2026
The global Poly(L-lactide-co-caprolactone) market was valued at US$ 18.14 million in 2025 and is anticipated to reach US$ 29.32 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 116
USD 2900.00
(Single User License)
Global Poly(L-lactide-co-caprolactone) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Poly(L-lactide-co-caprolactone) market size was US$ 17 million in 2024 and is forecast to a readjusted size of US$ 27.5 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 70
USD 4250.00
(Single User License)
Poly(L-lactide-co-caprolactone)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Poly(L-lactide-co-caprolactone) was estimated to be worth US$ 17 million in 2024 and is forecast to a readjusted size of US$ 27.5 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 86
USD 3950.00
(Single User License)
Global Poly(L-lactide-co-caprolactone) Market Research Report 2025
The global market for Poly(L-lactide-co-caprolactone) was valued at US$ 17 million in the year 2024 and is projected to reach a revised size of US$ 27.5 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published Date: 2025-01-13
Pages: 83
USD 2900.00
(Single User License)
Global Poly(L-lactide-co-caprolactone) Market Insights, Forecast to 2030
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
Published Date: 2024-04-15
Pages: 70
USD 4900.00
(Single User License)
Global Poly(L-lactide-co-caprolactone) Market Research Report 2024
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
Published Date: 2024-01-17
Pages: 83
USD 2900.00
(Single User License)
Poly(L-lactide-co-caprolactone)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Poly(L-lactide-co-caprolactone) was estimated to be worth US$ 18.14 million in 2025 and is projected to reach US$ 29.32 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-06-16
Pages: 119
USD 3950.00 (Single User License)Global Poly(L-lactide-co-caprolactone) Market Research Report 2026
The global Poly(L-lactide-co-caprolactone) market was valued at US$ 18.14 million in 2025 and is anticipated to reach US$ 29.32 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-04-18
Pages: 116
USD 2900.00 (Single User License)Global Poly(L-lactide-co-caprolactone) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Poly(L-lactide-co-caprolactone) market size was US$ 17 million in 2024 and is forecast to a readjusted size of US$ 27.5 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 70
USD 4250.00 (Single User License)Poly(L-lactide-co-caprolactone)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Poly(L-lactide-co-caprolactone) was estimated to be worth US$ 17 million in 2024 and is forecast to a readjusted size of US$ 27.5 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 86
USD 3950.00 (Single User License)Global Poly(L-lactide-co-caprolactone) Market Research Report 2025
The global market for Poly(L-lactide-co-caprolactone) was valued at US$ 17 million in the year 2024 and is projected to reach a revised size of US$ 27.5 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published: 2025-01-13
Pages: 83
USD 2900.00 (Single User License)Global Poly(L-lactide-co-caprolactone) Market Insights, Forecast to 2030
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
Published: 2024-04-15
Pages: 70
USD 4900.00 (Single User License)Global Poly(L-lactide-co-caprolactone) Market Research Report 2024
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
Published: 2024-01-17
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now